Czech J. Food Sci., 2017, 35(4):285-310 | DOI: 10.17221/584/2015-CJFS

Curcumin and its allied analogues: epigenetic and health perspectives - a reviewReview

Muhammad Imran1, Muhammad Nadeem2, Muhammad Asif Khan3, Sheraz Ahmed4, Ali Imran*,5, Rai Muhammad Amir6, Muhammad Umair Arshad5, Syed Amir Gilani7, Farhan Saeed5, Abdur Rauf8, Zaffar Mehmood9, Shaista Khan10, Hafiz Ansar Rasul Suleria11
1 Department of Diet and Nutritional Sciences, Imperial College of Business Studies, Lahore, Pakistan
2 Department of Environmental Sciences, CoMsaTs Institute of Information Technology, Vehari, Pakistan
3 University of Agriculture, Faisalabad-sub Campus Burewala/Vehari, Pakistan
4 Department of Food Science and Technology, Islamia University of Bhawalpur, Bhawalpur, Pakistan
5 Faculty of Home and Food Sciences, Government College University, Faisalabad, Pakistan
6 Institute of Food and Nutritional Sciences, Pmas-Arid Agriculture University, Rawalpindi, Pakistan
7 Faculty of Allied Health Sciences, University of Lahore, Lahore, Pakistan
8 Department of Chemistry, University of Swabi, Ankbar Swabi, Pakistan
9 Department of Biological Sciences, Forman Christian College, Lahore, Pakistan
10 Department of Molecular Biology and Genetics, Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan
11 Translational Research Institute, University of Queensland, School of Medicine, Brisbane, Australia

Curcumin (diferuoyl methane) is a yellow active ingredient present in turmeric. It is a homodimer of feruloylmethane that comprises a hydroxyl and methoxy group (heptadiene with two Michael acceptors), and α-, β-diketone. It contains various metabolites, i.e. hexahydrocurcumin (HHC), tetrahydrocurcumin (THC), octahydrocurcumin (OHC), dihydrocurcumin (DHC), curcumin sulphate, and curcumin glucuronide. Curcumin has been proven the most effective histone deacetylase (HDAC) inhibitor in HeLa nuclear extracts. It has the ability to affect the Akt, growth factors, NF-kB, and metastatic and angiogenic pathways. Curcumin has a strong therapeutic or preventive potential against several major human ailments, i.e. suppression of inflammation, cardiovascular, diabetes, tumorigenesis, chronic fatigue, antidepressant and neurological activities, depression, loss of muscle and bone, and neuropathic pain. In future, higher utilisation of curcumin as an active agent in food based products is required to curtail the human health disorders.

Keywords: turmeric; chemistry and metabolism; epigenetic role; anticancer; low toxicity

Published: August 31, 2017  Show citation

ACS AIP APA ASA Harvard Chicago IEEE ISO690 MLA NLM Turabian Vancouver
Imran M, Nadeem M, Khan MA, Ahmed S, Imran A, Amir RM, et al.. Curcumin and its allied analogues: epigenetic and health perspectives - a review. Czech J. Food Sci.. 2017;35(4):285-310. doi: 10.17221/584/2015-CJFS.
Download citation

References

  1. Abdou A.G., Hanout H.M. (2008): Evaluation of survivin and NF-κB in psoriasis, an immunohistochemical study. Journal of Cutaneous Pathology. 35: 445-451. Go to original source... Go to PubMed...
  2. Aggarwal B.B., Sung B. (2009): Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends in Pharmacological Sciences, 30: 85-94. Go to original source... Go to PubMed...
  3. Aggarwal B.B., Kumar A., Bharti A.C. (2003): Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Research. 23 (1A): 363-398.
  4. Ammon H.P., Wahl M.A. (1991): Pharmacology of Curcuma longa. Planta Medica, 57: 1-7. Go to original source... Go to PubMed...
  5. Anand P, Kunnumakkara A.B., Newman R.A., Aggarwal B.B. (2007): Bioavailability of curcumin: problems and promises. Molecular Pharmaceutics, 4: 807-818. Go to original source... Go to PubMed...
  6. Araújo C.C, Leon L.L. (2001): Biological activities of Curcuma longa L. Memorias do Instituto Oswaldo Cruz, 96: 723-728. Go to original source... Go to PubMed...
  7. Asai A., Miyazawa T. (2001): Dietary curcuminoids prevent high-fat diet-induced lipid accumulation in rat liver and epididymal adipose tissue. The Journal of Nutrition, 131: 2932-2935. Go to original source... Go to PubMed...
  8. Backs J., Olson E.N. (2006): Control of cardiac growth by histone acetylation/deacetylation. Circulation Research, 98: 15-24. Go to original source... Go to PubMed...
  9. Balasubramanyam K., Varier R.A., Altaf M., Swaminathan V., Siddappa N.B., Ranga U., Kundu T.K. (2004): Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. The Journal of Biological Chemistry, 279: 51163-51171. Go to original source... Go to PubMed...
  10. Balogun, E., Hoque M., Gong P., Killeen E., Green C.J., Foresti R., Alam J., Motterlini R. (2003): Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochemistry Journal, 371: 887-895. Go to original source... Go to PubMed...
  11. Bansal S.S., Kausar H., Aqil F., Jeyabalan J., Vadhanam M.V., Gupta R.C., Ravoori S. (2011): Curcumin implants for continuous systemic delivery: safety and biocompatibility. Drug Delivery and Translational Research, 1: 332-341. Go to original source... Go to PubMed...
  12. Baum L., Lam C.W., Cheung S.K., Kwok T., Lui V., Tsoh J., Lam L., Leung V., Hui E., Ng C., Woo J., Chiu H.F., Goggins W.B., Zee B.C., Cheng K.F., Fong C.Y., Wong A., Mok H., Chow M.S., Ho P.C., Ip S.P., Ho C.S., Yu X.W., Lai C.Y., Chan M.H., Szeto S., Chan I.H., Mok V. (2008): Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. Journal of Clinical Psychopharmacology, 28: 110-113. Go to original source... Go to PubMed...
  13. Beevers C.S., Huang S. (2011): Pharmacological and clinical properties of curcumin. Botanics: Targets and Therapy, 1: 5-18. Go to original source...
  14. Bernabé-Pineda M., Ramírez-Silva M.T., Romero-Romo M.A., González-Vergara E., Rojas-Hernández A. (2004): Spectrophotometric and electrochemical determination of the formation constants of the complexes CurcuminFe(III)-water and Curcumin-Fe(II)-water. Spectrochimica Acta A: Molecular and Biomolecular Spectroscopy, 60: 1105-1113. Go to original source... Go to PubMed...
  15. Bharti A.C., Takada Y., Aggarwal B.B. (2004): Curcumin (diferuloylmethane) inhibits receptor activator of NF-kappa B ligand-induced NF-kappa B activation in osteoclast precursors and suppresses osteoclastogenesis. Journal of Immunology, 172: 5940-5947. Go to original source... Go to PubMed...
  16. Bhaumik S., Jyothi M.D., Khar A. (2000): Differential modulation of nitric oxide production by curcumin in host macrophages and NK cells. FEBS Letters, 483: 78-82. Go to original source... Go to PubMed...
  17. Bhawana B.R.K., Buttar H.S., Jain V.K., Jain N. (2011): Curcumin nanoparticles: preparation, characterization, and antimicrobial study. Journal of Agricultural and Food Chemistry, 59: 2056-2061. Go to original source... Go to PubMed...
  18. Biswas S.K., McClure D., Jimenez L.A., Megson I.L., Rahman I. (2005): Curcumin induces glutathione biosynthesis and inhibits NF-κB activation and interleukin-8 release in alveolar epithelial cells: mechanism of free radical scavenging activity. Antioxidants & Redox Signaling, 7: 32-41. Go to original source... Go to PubMed...
  19. Black J.C., Choi J.E., Lombardo S.R., Carey M. (2006): A mechanism for coordinating chromatin modification and preinitiation complex assembly. Molecular Cell, 23: 809-818. Go to original source... Go to PubMed...
  20. Bloomgarden Z.T. (2007): Diabetes and obesity: part 1. Diabetes Care, 30: 3145-3151. Go to original source... Go to PubMed...
  21. Bondì M.L., Emma M.R., Botto C., Augello G., Azzolina A., DiGaudio F., Craparo E.F., Cavallaro G., Bachvarov D., Cervello M. (2017): Biocompatible lipid nanoparticles as carriers to improve curcumin efficacy in ovarian cancer treatment, Journal of Agricultural and Food Chemistry, 65: 1342-1352. Go to original source... Go to PubMed...
  22. Bora-Tatar G., DayangaÇ-Erden, Demir A.S., Dalkara S., YelekÇ K., Erdem-Yurter H. (2009): Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: activity and docking studies Bioorganic and Medicinal Chemistry, 17: 5219-5228. Go to original source... Go to PubMed...
  23. Brooks P.M. (2002): Impact of osteoarthritis on individuals and society: how much disability? Social consequences and health economic implications. Current Opinion in Rheumatology, 14: 573-577. Go to original source... Go to PubMed...
  24. Brouet I., Ohshima H. (1995): Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Biochemical and Biophysical Research Communications, 206: 533-540. Go to original source... Go to PubMed...
  25. Bruck R., Ashkenazi M., Weiss S., Goldiner I., Shapiro H., Aeed H., Genina O., Helpern Z., Pines M. (2007): Prevention of liver cirrhosis in rats by curcumin. Liver International, 27: 373-383. Go to original source... Go to PubMed...
  26. Bush J.A., Cheung K.J. Jr., Li G. (2001): Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53. Experimental Cell Research, 271: 305-314. Go to original source... Go to PubMed...
  27. Cay M., Naziroğlu M., Simsek H., Aydilek N., Aksakal M., Demirci M. (2001): Effects of intraperitoneally administered vitamin C on antioxidative defense mechanism in rats with diabetes induced by streptozotocin. Research in Experimental Medicine, 200: 205-213.
  28. Chan M.M., Huang H.I., Fenton M.R., Fong D. (1998): In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties. Biochemical Pharmacology, 55: 1955-1962. Go to original source... Go to PubMed...
  29. Chang D.M. (2001): Curcumin: a heat shock response inducer and potential cytoprotector. Critical Care Medicine, 29: 2231-2232. Go to original source... Go to PubMed...
  30. Chang M.T., Tsai T.R., Lee C.Y., Wei Y.S., Chen Y.J., Chen C.R. (2013): Elevating bioavailability of curcumin via encapsulation with a novel formulation of artificial oil bodies. Journal of Agricultural and Food Chemistry, 61: 9666-9671. Go to original source... Go to PubMed...
  31. Chattopadhyay I., Biswas K., Bandyopadhyay U., Banerjee R.K. (2004): Turmeric and curcumin: biological actions and medicinal applications. Current Science, 87: 44-53.
  32. Chen Y., Shu W., Chen W., Wu Q., Liu H., Cui G. (2007): Curcumin, both histone deacetylase and p300/CBPspecific inhibitor, represses the activity of nuclear factor kappa B and Notch 1 in Raji cells. Basic and Clinical and Pharmacological Toxicology, 101: 427-433. Go to original source... Go to PubMed...
  33. Chen Y.C., Tsai S.H., Shen S.C., Lin J.K., Lee W.R. (2001): Alternative activation of extracellular signal-regulated protein kinases in curcumin and arsenite-induced HSP70 gene expression in human colorectal carcinoma cells. European Journal of Cell Biology, 80: 213-221. Go to original source... Go to PubMed...
  34. Cheng A.L., Hsu C.H., Lin J.K., Hsu M.M., Ho Y.F., Shen T.S., Ko J.Y., Lin J.T., Lin B.R., Ming-Shiang W., Yu H.S., Jee S.H., Chen G.S., Chen T.M., Chen C.A., Lai M.K., Pu Y.S., Pan M.H., Wang Y.J., Tsai C.C., Hsieh C.Y. (2001): Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Research, 21: 2895-2900.
  35. Cho J.W., Lee K.S., Kim C.W. (2007): Curcumin attenuates the expression of IL-1beta, IL-6, and TNF-alpha as well as cyclin E in TNF-alpha-treated HaCaT cells; NF-kappaB and MAPKs as potential upstream targets. International Journal of Molecular Medicine; 19: 469-474. Go to original source...
  36. Citron M. (2002): Alzheimer's disease: treatments in discovery and development. National Neuroscience, l: 1055-1057. Go to original source...
  37. Citron M. (2004): Strategies for disease modification in Alzheimer's disease. Natural reviews. Neuroscience, 5: 677-685. Go to original source... Go to PubMed...
  38. Cole G.M., Teter B., Frautschy S.A. (2007): Neuroprotective effects of curcumin. Advances in Experimental Medicine and Biology, 595: 197-212. Go to original source... Go to PubMed...
  39. Dai C., Li D, Gong L., Xiao X., Tang S. (2016): Curcumin ameliorates furazolidone-induced DNA damage and apoptosis in human hepatocyte L02 Cells by inhibiting ROS production and mitochondrial pathway. Molecules, 21, 1061. doi: 10.3390/molecules21081061 Go to original source... Go to PubMed...
  40. Dar A., Khatoon S. (2000): Behavioral and biochemical studies of dichloromethane fraction from the Areca catechu nut. Pharmacology, Biochemistry and Behavior, 65: 1-6. Go to original source... Go to PubMed...
  41. Deeb D., Jiang H., Gao X., Hafner M.S., Wong H., Divine G., Chapman R.A., Dulchavsky S.A., Gautam S.C. (2004): Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-kappaB through suppression of I kappa B alpha phosphorylation. Molecular Cancer Therapeutics, 3: 803-812. Go to original source...
  42. Dekker F.J., Ghizzoni M., van der Meer N., Wisastra R., Haisma H.J. (2009): Inhibition of the PCAF histone acetyl transferase and cell proliferation by isothiazolones. Bioorganic and Medicinal Chemistry, 17: 460-466. Go to original source... Go to PubMed...
  43. Duvoix A., Blasius R., Delhalle S., Schnekenburger M., Morceau F., Henry E., Dicato M., Diederich M. (2005): Chemopreventive and therapeutic effects of curcumin. Cancer Letters, 223: 181-190. Go to original source... Go to PubMed...
  44. Ehrlich M. (2009): DNA hypomethylation in cancer cells. Epigenomics, 1: 239-259. Go to original source... Go to PubMed...
  45. Elsharkawy A.M., Oakley F., Mann D.A. (2005): The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis. Apoptosis, 10: 927-939. Go to original source... Go to PubMed...
  46. Farhangkhoee H., Khan Z.A., Chen S., Chakrabarti S. (2006): Differential effects of curcumin on vasoactive factors in the diabetic rat heart. Nutrition and Metabolism, 18, 3: 27. doi: 10.1186/1743-7075-3-27 Go to original source... Go to PubMed...
  47. Ferreira N., Sónia A.O., Santos M., Rosário M., Domingues M., Maria J.S., Maria R.A. (2013): Dietary curcumin counteracts extracellular transthyretin deposition: Insights on the mechanism of amyloid inhibition. Biochimica et Biophysica Acta-Molecular Basis of Disease, 1832: 39-45. Go to original source... Go to PubMed...
  48. Fujiwara H., Hosokawa M., Zhou X. (2008): Curcumin inhibits glucose production in isolated mice hepatocytes. Diabetes Research and Clinical Practice, 80: 185-191. Go to original source... Go to PubMed...
  49. Garcea G., Jones D.J., Singh R., Dennison A.R., Farmer P.B., Sharma R.A., Steward W.P., Gescher A.J., Berry D.P. (2004): Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration. British Journal of Cancer, 90: 1011-1015. Go to original source... Go to PubMed...
  50. García-Niño W.R., Pedraza-Chaverrí J. (2014): Protective effect of curcumin against heavy metals-induced liver damage. Food and Chemical Toxicology, 69: 182-201. Go to original source... Go to PubMed...
  51. Gardner D.G. (2003): Natriuretic peptides: markers or modulators of cardiac hypertrophy? Trends in Endocrinology and Metabolism, 14: 411-416. Go to original source... Go to PubMed...
  52. Goel A., Boland C.R., Chauhan D.P. (2001): Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells. Cancer Letters, 172: 111-118. Go to original source... Go to PubMed...
  53. Gonzales A.M., Orlando R.A. (2008): Curcumin and resveratrol inhibit nuclear factor-κB-mediated cytokine expression in adipocytes. Nutrition and Metabolism, 5: 17. doi: 10.1186/1743-7075-5-17 Go to original source... Go to PubMed...
  54. Gopinath D., Ahmed M.R., Gomathi K., Chitra K., Sehgal P.K., Jayakumar R. (2004): Dermal wound healing processes with curcumin incorporated collagen films. Biomaterials, 25: 1911-1917. Go to original source... Go to PubMed...
  55. Gupta S.K., Kumar B., Nag T.C. (2011): Curcumin prevents experimental diabetic retinopathy in rats through its hypoglycemic, antioxidant, and anti-inflammatory mechanisms. Journal of Ocular Pharmacology and Therapeutics, 27: 123-130. Go to original source... Go to PubMed...
  56. Hahm E.R., Gho Y.S., Park S., Park C., Kim K.W., Yang C.H. (2004): Synthetic curcumin analogs inhibit activator protein-1 transcription and tumor-induced angiogenesis. Biochemical and Biophysical Research Communications, 321: 337-344. Go to original source... Go to PubMed...
  57. Halliwell B., Gutteridge J.M.C. (2002): Free Radicals in Biology and Medicine. 3rd Ed. New York, Oxford University Press Inc.: 105-245.
  58. Han Y.R., Zhu J.J., Wang Y.R., Wang X.S., Liao Y.H. (2011): A simple RP-HPLC method for the simultaneous determination of curcumin and its prodrug, curcumin didecanoate, in rat plasma and the application to pharmacokinetic study. Biomedical Chromatography, 25: 1144-1149. Go to original source... Go to PubMed...
  59. Heng M.C., Song M.K., Harker J., Heng M.K. (2000): Druginduced suppression of phosphorylase kinase activity correlates with resolution of psoriasis as assessed by clinical, histological and immunohistochemical parameters. British Journal of Dermatology, 143: 937-949. Go to original source... Go to PubMed...
  60. Hong J., Bose M., Ju J., Ryu J.H., Chen X., Sang S., Lee M.J., Yang C.S. (2004): Modulation of arachidonic acid metabolism by curcumin and related beta-diketone derivatives: effects on cytosolic phospholipase A(2), cyclooxygenases and 5-lipoxygenase. Carcinogenesis, 25: 1671-1679. Go to original source... Go to PubMed...
  61. Hsu C.H., Cheng A.L. (2007): Clinical studies with curcumin. Advances in Experimental Medicine and Biology, 595: 471-480. Go to original source... Go to PubMed...
  62. Hunt J.S., Petroff M.G., Morales P., Sedlmayr P., Geraghty D.E., Ober C. (2000): HLA-G in reproduction: studies on the maternal-fetal interface. Human Immunology, 61: 1113-1117. Go to original source... Go to PubMed...
  63. Hussan F., Ibraheem N.G., Kamarudin T.A., Shuid A.N., Soelaiman I.N., Othman F. (2012): Curcumin protects against ovariectomy-induced bone changes in rat model. Evidence-Based Complementary and Alternative Medicine, 2012, Article ID 174916. doi: 10.1155/2012/174916 Go to original source... Go to PubMed...
  64. Illek B., Lizarzaburu M.E., Lee V., Nantz M.H., Kurth M.J., Fischer H. (2000): Structural determinants for activation and block of CFTR-mediated chloride currents by apigenin. American Journal of Physiology-Cell Physiology, 279: C1838-C1844. Go to original source... Go to PubMed...
  65. Iqbal M., Okazaki Y., Okada S. (2003): In vitro curcumin modulates ferric nitrilotriacetate (Fe-NTA) and hydrogen peroxide (H 2O 2)-induced peroxidation of microsomal membrane lipids and DNA damage. Teratogenesis, Carcinogenesis, and Mutagenesis, 1: 151-160. Go to original source... Go to PubMed...
  66. Ireson C., Orr S., Jones D.J., Verschoyle R., Lim C.K., Luo J.L., Howells L., Plummer S., Jukes R., Williams M., Steward W.P., Gescher A. (2001): Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production. Cancer Research, 61: 1058-1064.
  67. Ireson C.R., Jones D.J., Orr S., Coughtrie M.W., Boocock D.J., Williams M.L., Farmer P.B., Steward W.P., Gescher A.J. (2002): Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiology, Biomarkers and Prevention, 11: 105-111.
  68. Jagetia G.C., Rajanikant G.K. (2005): Curcumin treatment enhances the repair and regeneration of wounds in mice exposed to hemibody gamma-irradiation. Plastic and Reconstructive Surgery, 115: 515-528. Go to original source... Go to PubMed...
  69. Jana N.R., Dikshit P., Goswami A., Nukina N. (2004): Inhibition of proteasomal function by curcumin induces apoptosis through mitochondrial pathway. Journal of Biological Chemistry, 279: 11680-11685. Go to original source... Go to PubMed...
  70. Jaruga E., Salvioli S., Dobrucki J., Chrul S., BandorowiczPiku³a J., Sikora E., Franceschi C., Cossarizza A., Bartosz G. (1998a): Apoptosis-like, reversible changes in plasma membrane asymmetry and permeability, and transient modifications in mitochondrial membrane potential induced by curcumin in rat thymocytes. FEBS Letters, 433: 287-293. Go to original source... Go to PubMed...
  71. Jaruga E., Sokal A., Chrul S., Bartosz G. (1998b): Apoptosisindependent alterations in membrane dynamics induced by curcumin. Experimental Cell Research, 245: 303-312. Go to original source... Go to PubMed...
  72. Joe B., Vijaykumar M., Lokesh B.R. (2004): Biological properties of curcumin-cellular and molecular mechanisms of action. Critical Reviews in Food Science and Nutrition, 44: 97-111. Go to original source... Go to PubMed...
  73. Kalpana C., Menon V.P. (2004): Curcumin ameliorates oxidative stress during nicotine-induced lung toxicity in Wistar rats. Italian Journal of Biochemistry, 53: 82-86.
  74. Kam A., Li K.M., Razmovski-Naumovski V., Nammi S., Chan K., Grau G.E., Li G.Q. (2015): Curcumin reduces tumour necrosis factor-enhanced Annexin V-positive microparticle release in human vascular endothelial cells. Journal of Pharmacy and Pharmaceutical Sciences, 18: 424-433. Go to original source... Go to PubMed...
  75. Kang S.K., Cha S.H., Jeon H.G. (2006): Curcumin-induced histone hypoacetylation enhances caspase-3-dependent glioma cell death and neurogenesis of neural progenitor cells. Stem Cells and Development, 15: 165-174. Go to original source... Go to PubMed...
  76. Karunagaran D., Rashmi R., Kumar T.R. (2005): Induction of apoptosis by curcumin and its implications for cancer therapy. Current Cancer Drug Targets, 5: 117-129. Go to original source... Go to PubMed...
  77. Kawamori T., Lubet R., Steele V.E., Kelloff G.J., Kaskey R.B., Rao C.V., Reddy B.S. (1999): Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. Cancer Research, 59: 597-601.
  78. Khopde S.M., Priyadarsini K.I., Guha S.N., Satav J.G., Venkatesan P., Rao M.N. (2000): Inhibition of radiation-induced lipid peroxidation by tetrahydrocurcumin: possible mechanisms by pulse radiolysis. Bioscience, Biotechnology, and Biochemistry, 64: 503-509. Go to original source... Go to PubMed...
  79. Kim H.Y., Park E.J., Joe E.H., Jou I. (2003): Curcumin suppresses Janus kinase-STAT inflammatory signaling through activation of Src homology 2 domain-containing tyrosine phosphatase 2 in brain microglia. Journal of Immunology, 171: 6072-6079. Go to original source... Go to PubMed...
  80. Kim J.H., Xu C., Keum Y.S., Reddy B., Conney A., Kong A.N. (2006): Inhibition of EGFR signaling in human prostate cancer PC-3 cells by combination treatment with betaphenylethyl isothiocyanate and curcumin. Carcinogenesis, 7: 475-482. Go to original source... Go to PubMed...
  81. Kim T., Davis J., Zhang A.J., He X., Mathews S.T. (2009): Curcumin activates AMPK and suppresses gluconeogenic gene expression in hepatoma cells. Biochemical and Biophysical Research Communications, 388: 377-338. Go to original source... Go to PubMed...
  82. Kim D.W., Sovak M.A., Zanieski G., Nonet G., RomieuMourez R., Lau A.W., Hafer L.J., Yaswen P., Stampfer M., Rogers A.E., Russo J., Sonenshein G.E. (2000): Activation of NF-kappaB/Rel occurs early during neoplastic transformation of mammary cells. Carcinogenesis, 21: 871-879. Go to original source... Go to PubMed...
  83. Kowluru R.A., Kanwar M. (2007): Effects of curcumin on retinal oxidative stress and inflammation in diabetes. Nutrition and Metabolism, 2007 4:8. doi: 10.1186/17437075-4-8 Go to original source... Go to PubMed...
  84. Kukongviriyapan U., Apaijit K., Kukongviriyapan V. (2016): Oxidative stress and cardiovascular dysfunction associated with cadmium exposure: beneficial effects of curcumin and tetrahydrocurcumin. Tohoku Journal of Experimental Medicine, 239: 25-38. Go to original source... Go to PubMed...
  85. Kulkarni S.K., Bhutani M.K., Bishnoi M. (2008): Antidepressant activity of curcumin: involvement of serotonin and dopamine system. Psychopharmacology (Berl), 20: 435-442. Go to original source... Go to PubMed...
  86. Kumar A., Kingdon E., Norman J. (2005): The isoprostane 8-iso-PGF2alpha suppresses monocyte adhesion to human microvascular endothelial cells via two independent mechanisms. FASEB Journal, 9: 443-445. Go to original source... Go to PubMed...
  87. Kurd S.K., Smith N., VanVoorhees A., Troxel A.B., Badmaev V., Seykora J.T., Gelfand J.M. (2008): Oral curcumin in the treatment of moderate to severe psoriasis vulgaris: a prospective clinical trial. Journal of the American Academy of Dermatology, 8: 625-631. Go to original source... Go to PubMed...
  88. Kurien B.T., Singh A., Matsumoto H., Scofield R.H. (2007): Improving the solubility and pharmacological efficacy of curcumin by heat treatment. ASSAY and Drug Development Technologies, 5: 567-576. Go to original source... Go to PubMed...
  89. Lee H.S. (2006): Antiplatelet property of Curcuma longa L. rhizome-derived ar-turmerone. Bioresource Technology, 97: 1372-1376. Go to original source... Go to PubMed...
  90. Lee J.J., Huang W.T., Shao D.Z., Liao J.F., Lin M.T. (2003): Blocking NF-kappaB activation may be an effective strategy in the fever therapy. Japanese Journal of Physiology, 3: 367-375. Go to original source... Go to PubMed...
  91. Lee C.K., Ki S.H., Choi J.S. (2011): Effects of oral curcumin on the pharmacokinetics of intravenous and oral etoposide in rats: possible role of intestinal CYP3A and P-gp inhibition by curcumin. Biopharmaceutics and Drug Disposition, 32: 245-251. Go to original source... Go to PubMed...
  92. Lee K.H., Chow Y.L., Sharmili V., Abas F., Alitheen N.B., Shaari K., Israf D.A., Lajis N.H., Syahida A. (2012): BDMC33, a curcumin derivative suppresses inflammatory responses in macrophage-like cellular system: role of inhibition in NF-κB and MAPK signaling pathways. International Journal of Molecular Sciences, 13: 2985-3008. Go to original source... Go to PubMed...
  93. Lelli D., Pedone C., Sahebkar A. (2017): Curcumin and treatment of melanoma: The potential role of microRNAs. Biomedicine and Pharmacotheraphy, 88: 832-834. Go to original source... Go to PubMed...
  94. Liao S., Lin J., Dang M.T., Zhang H., Kao Y.H., Fukuchi J., Hiipakka R.A. (2001): Growth suppression of hamster flank organs by topical application of catechins, alizarin, curcumin, and myristoleic acid. Archives of Dermatological Research, 293: 200-205. Go to original source... Go to PubMed...
  95. Lim G.P., Chu T., Yang F., Beech W., Frautschy S.A., Cole G.M. (2001): The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. Journal of Neuroscience, 21: 8370-8377. Go to original source... Go to PubMed...
  96. Literat A., Su F., Norwicki M., Durand M., Ramanathan R., Jones C.A., Minoo P., Kwong K.Y. (2001): Regulation of pro-inflammatory cytokine expression by curcumin in hyaline membrane disease (HMD). Life Sciences, 70: 253-267. Go to original source... Go to PubMed...
  97. Liu C.H., Chang F.Y. (2011): Development and characterization of eucalyptol microemulsions for topic delivery of curcumin. Chemical and Pharmaceutical Bulletin, 59: 172-178. Go to original source... Go to PubMed...
  98. Liu Z.J., Han G., Yu J.G., Dai H.G. (2009): Preparation and drug releasing property of curcumin nanoparticles. Zhong Yao Cai, 32: 277-279.
  99. Liu H., Moroi Y., Yasumoto S., Kokuba H., Imafuku S., Nakahara T., Dainichi T., Uchi H., Tu Y., Furue M., Urabe K. (2006): Immunohistochemical localization of activated Stat3 and hTERT protein in psoriasis vulgaris. European Journal of Dermatology, 16: 205-207.
  100. Liu R., Liu Z., Zhang C., Zhang B. (2011): Gelucire44/14 as a novel absorption enhancer for drugs with different hydrophilicities: in vitro and in vivo improvement on transcorneal permeation. Journal of Pharmaceutical Sciences, 100: 3186-3195. Go to original source... Go to PubMed...
  101. Lodha R., Bagga A. (2000): Traditional Indian systems of medicine. Annals, Academy of Medicine, Singapore, 29: 37-41.
  102. Lohse M.J., Engelhardt S., Eschenhagen T. (2003a): What is the role of beta-adrenergic signaling in heart failure? Circulation Research, 93: 896-906. Go to original source... Go to PubMed...
  103. Lohse M.J., Vilardaga J.P., Bunemann M. (2003b): Direct optical recording of intrinsic efficacy at a G proteincoupled receptor. Life Sciences, 74: 397-404. Go to original source... Go to PubMed...
  104. Mani H., Sidhu G.S., Kumari R., Gaddipati J.P., Seth P., Maheshwari R.K. (2002): Curcumin differentially egulates TGF-β1, its receptors and nitric oxide synthase during impaired wound healing. BioFactors, 16: 29-43. Go to original source... Go to PubMed...
  105. Manikandan P., Sumitra M., Aishwarya S., Manohar B.M., Lokanadam B., Puvanakrishnan R. (2004): Curcumin modulates free radical quenching in myocardial ischaemia in rats. International Journal of Biochemistry and Cell Biology, 6: 1967-1980. Go to original source... Go to PubMed...
  106. Marcu M.G., Jung Y.J., Lee S., Chung E.J., Lee M.J., Trepel J., Neckers L. (2006): Curcumin is an inhibitor of p300 histone acetylatransferase. Journal of Medicinal Chemistry, 2: 169-174. Go to original source... Go to PubMed...
  107. Marwick J.A., Ito K., Adcock I.M., Kirkham P.A. (2007): Oxidative stress and steroid resistance in asthma and COPD: pharmacological manipulation of HDAC-2 as a therapeutic strategy. Expert Opinion in Therapeutics Targets, 11: 745-755. Go to original source... Go to PubMed...
  108. Mayanglambam A., Dangelmaier C.A., Thomas D., Reddy C.D., Daniel J.L., Kunapuli S.P. (2010): Curcumin inhibits GPVI-mediated platelet activation by interfering with the kinase activity of Syk and the subsequent activation of PLCã2. Platelets, 21: 211-220. Go to original source... Go to PubMed...
  109. Meja K.K., Rajendrasozhan S., Adenuga D., Biswas S.K., Sundar I.K., Spooner G., Marwick J.A., Chakravarty P., Fletcher D., Whittaker P., Megson I.L., Kirkham P.A., Rahman I. (2008): Curcumin restores corticosteroid function in monocytes exposed to oxidants by maintaining HDAC2. American Journal of Respiratory Cell and Molecular Biology, 39: 312-323. Go to original source... Go to PubMed...
  110. Miyamoto S., Kawamura T., Morimoto T., Ono K., Wada H., Kawase Y., Matsumori A., Nishio R., Kita T., Hasegawa K. (2006): Histone acetyltransferase activity of p300 is required for the promotion of left ventricular remodeling after myocardial infarction in adult mice in vivo. Circulation, 113: 679-690. Go to original source... Go to PubMed...
  111. Morimoto T., Sunagawa Y., Kawamura T., Takaya T., Wada H., Nagasawa A., Komeda M., Fujita M., Shimatsu A., Kita T., Hasegawa K. (2008): The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats. Journal of Clinical Investigation, 118: 868-878. Go to original source... Go to PubMed...
  112. Motterlini R., Foresti R., Bassi R., Green C.J. (2000): Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radical Biology and Medicine, 28: 1303-1312. Go to original source... Go to PubMed...
  113. Motterlini R., Green C.J., Foresti R. (2002): Regulation of heme oxygenase-1 by redox signals involving nitric oxide. Antioxidants and Redox Signaling, 4: 615-624. Go to original source... Go to PubMed...
  114. Mukhopadhyay A., Bueso-Ramos C., Chatterjee D., Pantazis P., Aggarwal B.B. (2001): Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines. Oncogenesis, 20: 7597-7609. Go to original source... Go to PubMed...
  115. Naito M., Wu X., Nomura H., Kodama M., Kato Y., Kato Y., Osawa T. (2002): The protective effects of tetrahydrocurcumin on oxidative stress in cholesterol-fed rabbits. Journal of Atherosclerosis and Thrombosis, 9: 243-250. Go to original source... Go to PubMed...
  116. Narayan S. (2004): Curcumin, a multi-functional chemopreventive agent, blocks growth of colon cancer cells by targeting beta-catenin-mediated transactivation and cell-cell adhesion pathways. Journal of Molecular Histology, 35: 301-307. Go to original source... Go to PubMed...
  117. Nariya A., Pathan A., Shah N., Chettiar S., Patel A., Dattani J., Chandel D., Rao M., Jhala D. (2017): Ameliorative effects of curcumin against lead induced toxicity in human peripheral blood lymphocytes culture. Drug and Chemical Toxicology, 1: 1-8. Go to original source... Go to PubMed...
  118. Neuman M.G. (2003): Cytokines - central factors in alcoholic liver disease. Alcohol Research and Health, 27: 307-216.
  119. Oakley F., Mann J., Nailard S., Smart D.E., Mungalsingh N., Constandinou C., Ali S., Wilson S.J., Millward-Sadler H., Iredale J.P., Mann D.A. (2005): Nuclear factor-кB1 (p50) limits the inflammatory and fibrogenic responses to chronic injury. American Journal of Pathology, 166: 695-708. Go to original source... Go to PubMed...
  120. Okada K., Wangpoengtrakul C., Tanaka T., Toyokuni S., Uchida K., Osawa T. (2011): Curcumin and especially tetrahydrocurcumin ameliorate oxidative stress-induced renal injury in mice. Journal of Nutrition, 131: 2090-2095. Go to original source... Go to PubMed...
  121. Olszanecki R., Jawieñ J., Gajda M., Mateuszuk L., Gebska A., Korabiowska M., Ch³opicki S., Korbut R. (2005): Effect of curcumin on atherosclerosis in apoE/LDLR-double knockout mice. Journal of Physiology and Pharmacology, 56: 627-635.
  122. Ono K., Hasegawa K., Naiki H., Yamada M. (2004): Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro. Journal of Neurosciences Research, 75: 742-750. Go to original source... Go to PubMed...
  123. Ozaki K., Kawata Y., Amano S., Hanazawa S. (2000): Stimulatory effect of curcumin on osteoclast apoptosis. Biochemical Pharmacology, 59: 1577-1581. Go to original source... Go to PubMed...
  124. Padmaja S., Raju T.N. (2004): Antioxidant effect of curcumin in selenium induced cataract of Wistar rats. Indian Journal of Experimental Biology, 42: 601-603.
  125. Pan M.H., Lin-Shiau S.Y., Lin J.K. (2000): Comparative studies on the suppression of nitric oxide synthase by curcumin and its hydrogenated metabolites through downregulation of IkappaB kinase and NFkappaB activation in macrophages. Biochemical Pharmacology, 60: 1665-1676. Go to original source... Go to PubMed...
  126. Pandelidou M., Dimas K., Georgopoulos A., Hatziantoniou S., Demetzos C. (2011): Preparation and characterization of lyophilised egg PC liposomes incorporating curcumin and evaluation of its activity against colorectal cancer cell lines. Journal of Nanoscience and Nanotechnology, 11: 1259-1266. Go to original source... Go to PubMed...
  127. Pandya U., Saini M.K., Jin G.F., Awasthi S., Godley B.F., Awasthi Y.C. (2000): Dietary curcumin prevents ocular toxicity of naphthalene in rats. Toxicology Letters, 115: 195-204. Go to original source... Go to PubMed...
  128. Pari L., Murugan P. (2004): Protective role of tetrahydrocurcumin against erythromycin estolate-induced hepatotoxicity. Pharmacological Research, 49: 481-486. Go to original source... Go to PubMed...
  129. Pari L., Amali D.R. (2005): Protective role of tetrahydrocurcumin (THC) an active principle of turmeric on chloroquine induced hepatotoxicity in rats. Journal of Pharmacology and Pharmaceutical Sciences, 8: 115-123.
  130. Pari L., Murugan P. (2005): Effect of tetrahydrocurcumin on blood glucose, plasma insulin and hepatic key enzymes in streptozotocin induced diabetic rats. Journal of Basic and Clinical Physiology and Pharmacology, 16: 257-274. Go to original source... Go to PubMed...
  131. Pari L., Murugan P. (2006): Tetrahydrocurcumin: effect on chloroquine-mediated oxidative damage in rat kidney. Basic and Clinical Pharmacology and Toxicology, 99: 329-334. Go to original source... Go to PubMed...
  132. Park E.J., Jeon C.H., Ko G., Kim J., Sohn D.H. (2000): Protective effect of curcumin in rat liver injury induced by carbon tetrachloride. Journal of Pharmacy and Pharmacology, 52: 437-440. Go to original source... Go to PubMed...
  133. Payton F., Sandusky P., Alworth W.L. (2007): NMR study of the solution structure of curcumin. Journal of Natural Products, 70: 143-146. Go to original source... Go to PubMed...
  134. Peschel D., Koerting R., Nass N. (2007): Curcumin induces changes in expression of genes involved in cholesterol homeostasis. Journal of Nutritional Biochemistry, 18: 113-119. Go to original source... Go to PubMed...
  135. Pfeiffer E., Hoehle S.I., Walch S.G., Riess A., Sólyom A.M., Metzler M. (2007): Curcuminoids form reactive glucuronides in vitro. Journal of Agricultural and Food Chemistry, 55: 538-544. Go to original source... Go to PubMed...
  136. Phan T.T., See P., Lee S.T., Chan S.Y. (2001): Protective effects of curcumin against oxidative damage on skin cells in vitro: its implication for wound healing. Journal of Trauma, 51: 927-931. Go to original source... Go to PubMed...
  137. Pol A., Bergers M., Schalkwijk J. (2003): Comparison of antiproliferative effects of experimental and established antipsoriatic drugs on human keratinocytes, using a simple 96-well-plate assay. In Vitro Cellular and Developmental Biology - Animal, 39: 36-42. Go to original source...
  138. Premanand C., Rema M., Sameer M.Z., Sujatha M., Balasubramanyam M. (2006): Effect of curcumin on proliferation of human retinal endothelial cells under in vitro conditions. Investigative Ophthalmology and Visual Science, 47: 2179-2184. Go to original source... Go to PubMed...
  139. Price L.C., Buescher R.W. (1997): Kinetics of alkaline degradation of the food pigments curcumin and curcuminoids. Journal of Food Sciences, 62: 267-269. Go to original source...
  140. Quaglino D., Nanney L.B., Kennedy R., Davidson J.M. (1990): Transforming growth factor-beta stimulates wound healing and modulates extracellular matrix gene expression in pig skin. I. Excisional wound model. Laboratory Investigation, 63: 307-319.
  141. Raisz L.G. (2005): Pathogenesis of osteoporosis: concepts, conflicts, and prospects. Journal of Clinical Investigation, 115: 3318-3325. Go to original source... Go to PubMed...
  142. Ram A., Das M., Ghosh B. (2003): Curcumin attenuates allergen-induced airway hyperresponsiveness in sensitized guinea pigs. Biological and Pharmaceutical Bulletin, 26: 1021-1024. Go to original source... Go to PubMed...
  143. Ramadori G., Armbrust T. (2001): Cytokines in the liver. European Journal of Gastroenterology and Hepatology, 13: 777-784. Go to original source... Go to PubMed...
  144. Ravindran J., Prasad S., Aggarwal B.B. (2009): Curcumin and cancer cells: how many ways can curry kill tumor cells selectively? AAPS Journal, 11: 495-510. Go to original source... Go to PubMed...
  145. Ray A., Rana S., Banerjee D., Mitra A., Datta R., Naskar S., Sarkar S. (2016): Improved bioavailability of targeted curcumin delivery efficiently regressed cardiac hypertrophy by modulating apoptotic load within cardiac microenvironment. Toxicology and Applied Pharmacology, 290: 54-65. Go to original source... Go to PubMed...
  146. Reddy P.H., Manczak M., Yin X., Grady M.C., Mitchell A., Kandimalla R., Kuruva C.S. (2016): Protective effects of a natural product, curcumin, against amyloid β induced mitochondrial and synaptic toxicities in Alzheimer's disease. Journal of Investigative Medicine, 64: 1220-1234. Go to original source... Go to PubMed...
  147. Renard P., Delaive E., Van Steenbrugge M., Remacle J., Raes M. (2001): Is the effect of interleukin-1 on glutathione oxidation in cultured human fibroblasts involved in nuclear factor-κB activation? Antioxidants and Redox Signaling, 3: 329-340. Go to original source... Go to PubMed...
  148. Rithaporn T., Monga M., Rajasekaran M. (2003): Curcumin: a potential vaginal contraceptive. Contraception, 68: 219-223. Go to original source... Go to PubMed...
  149. Sameermahmood Z., Balasubramanyam M., Saravanan T., Rema M. (2008): Curcumin modulates SDF-1α/CXCR4induced migration of human retinal endothelial cells (HRECs). Investigative Ophthalmology and Visual Science, 49: 3305-3311. Go to original source... Go to PubMed...
  150. Sandur S.K., Pandey M.K., Sung B., Ahn K.S., Murakami A., Sethi G., Limtrakul P., Badmaev V., Aggarwal B.B. (2007): Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. Carcinogenesis, 28: 1765-1773. Go to original source... Go to PubMed...
  151. Sano, M. (2007): p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature, 446: 444-448. Go to original source... Go to PubMed...
  152. Scapagnini G., Foresti R., Calabrese V., Giuffrida Stella A.M., Green C.J., Motterlini R. (2002): Caffeic acid phenethyl ester and curcumin: a novel class of heme oxygenase-1 inducers. Molecular Pharmacology, 61: 554-561. Go to original source... Go to PubMed...
  153. Shao J., Zheng D., Jiang Z., Xu H., Hu Y., Li X., Lu X. (2011): Curcumin delivery by methoxy polyethylene glycolpoly(caprolactone) nanoparticles inhibits the growth of C6 glioma cells. Acta Biochimica Biophysica Sinica (Shanghai), 43: 267-274. Go to original source... Go to PubMed...
  154. Shapiro H., Ashkenazi M., Weizman N., Shahmurov M., Aeed H., Bruck R. (2006): Curcumin ameliorates acute thioacetamide-induced hepatotoxicity. Journal of Gastroenterology and Hepatology, 21: 358-366. Go to original source... Go to PubMed...
  155. Sharma R.A., Euden S.A., Platton S.L., Cooke D.N., Shafayat A., Hewitt H.R., Marczylo T.H., Morgan B., Hemingway D., Plummer S.M., Pirmohamed M., Gescher A.J., Steward W.P. (2004): Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clinical Cancer Research, 10: 6847-6854. Go to original source... Go to PubMed...
  156. Sharma R.A., Steward W.P., Gescher A.J. (2007): Pharmacokinetics and pharmacodynamics of curcumin. Advances in Experimental Medicine and Biology, 595: 453-470. Go to original source... Go to PubMed...
  157. Sharma S., Chopra K., Kulkarni S.K. (2007): Effect of insulin and its combination with resveratrol or curcumin in attenuation of diabetic neuropathic pain: participation of nitric oxide and TNF-alpha. Phytotherapy Research, 21: 278-283. Go to original source... Go to PubMed...
  158. Shishodia S., Sethi G., Aggarwal B.B. (2005): Curcumin: getting back to the roots. Annals of New York Academy of Sciences, 1056: 206-217. Go to original source... Go to PubMed...
  159. Shoba G., Joy D., Joseph T., Majeed M., Rajendran R., Srinivas P.S. (1998): Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Medica, 64: 353-356. Go to original source... Go to PubMed...
  160. Simpson S.J., Holländer G.A., Mizoguchi E., Allen D., Bhan A.K., Wang B., Terhorst C. (1997): Expression of proinflammatory cytokines by TCR alpha beta+ and TCR gamma delta+ T cells in an experimental model of colitis. European Journal of Immunology, 27: 17-25. Go to original source... Go to PubMed...
  161. Singh S., Aggarwal B.B. (1995): Activation of transcription factor NF-κB is suppressed by curcumin (diferuloylmethane). Journal of Biological Chemistry, 270: 24995- 25000. Go to original source...
  162. Singh M., Sasi P., Gupta V.H., Rai G., Amarapurkar D.N., Wangikar P.P. (2012): Protective effect of curcumin, silymarin and N-acetylcysteine on antitubercular druginduced hepatotoxicity assessed in an in vitro model. Human and Experimental Toxicology, 31: 788-797. Go to original source... Go to PubMed...
  163. Singh N., Ranjan V., Zaidi D., Shyam H., Singh A., Lodha D., Sharma R., Verma U., Dixit J., Balapure A.K. (2012): Insulin catalyzes the curcumin-induced wound healing: an in vitro model for gingival repair. Indian Journal of Pharmacology, 44: 458-462. Go to original source... Go to PubMed...
  164. Srivastava K.C., Bordia A., Verma S.K. (1995): Curcumin, a major component of food spice turmeric (Curcuma longa) inhibits aggregation and alters eicosanoid metabolism in human blood platelets. Prostaglandins, Leukotrienes, and Essential Fatty Acids, 52: 223-227. Go to original source... Go to PubMed...
  165. Strimpakos A.S., Sharma R.A. (2008): Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials. Antioxidants and Redox Signaling, 10: 511-545. Go to original source... Go to PubMed...
  166. Suda T., Takahashi N., Udagawa N., Jimi E., Gillespie M.T., Marti T.J. (1999): Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocrine Reviews, 3: 345-357. Go to original source... Go to PubMed...
  167. Sugiyama Y., Kawakishi S., Osawa T. (1996): Involvement of the beta-diketone moiety in the antioxidative mechanisms of tetrahydrocurcumin. Biochemical Pharmacology, 52: 519-525. Go to original source... Go to PubMed...
  168. Sun J., Bi C., Chan H.M., Sun S., Zhang Q., Zheng Y. (2013): Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability. Colloids and Surfaces B: Biointerfaces, 111C: 367-375. Go to original source... Go to PubMed...
  169. Surh Y.J. (2003): Cancer chemoprevention with dietary phytochemicals. Nature Reviews Cancer, 3: 768-780. Go to original source... Go to PubMed...
  170. Surh Y.J., Chun K.S., Cha H.H., Han S.S., Keum Y.S., Park K.K., Lee S.S. (2001): Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-κB activation. Mutation Research, 480-481: 243-268. Go to original source... Go to PubMed...
  171. Thaloor D., Miller K.J., Gephart J., Mitchell P.O., Pavlath G.K. (1999): Systemic administration of the NF-κB inhibitor curcumin stimulates muscle regeneration after traumatic injury. American Journal of Physiology, 277: C320-C329. Go to original source... Go to PubMed...
  172. Thapa A., Jett S.D., Chi E.Y. (2016): Curcumin attenuates amyloid-β aggregate toxicity and modulates amyloid-β aggregation pathway. ACS Chemical Neuroscience, 7: 56-68. Go to original source... Go to PubMed...
  173. Thiyagarajan M., Sharma S.S. (2004): Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats. Life Sciences, 74: 969-985. Go to original source... Go to PubMed...
  174. Thompson K.H., Böhmerle K., Polishchuk E., Martins C., Toleikis P., Tse J., Yuen V., McNeill J.H., Orvig C. (2004): Complementary inhibition of synoviocyte, smooth muscle cell or mouse lymphoma cell proliferation by a vanadyl curcumin complex compared to curcumin alone. Journal od Inorganic Biochemistry, 98: 2063-2070. Go to original source... Go to PubMed...
  175. Tomita M., Matsuda T., Kawakami H., Uchihara J.N., Okudaira T., Masuda M., Ohshiro K., Mori N. (2006): Curcumin targets Akt cell survival signaling pathway in HTLV-Iinfected T-cell lines. Cancer Science, 97: 322-327. Go to original source... Go to PubMed...
  176. Tønnesen H.H., de Vries H., Karlsen J., Beijersbergen van Henegouwen G. (1987): Studies on curcumin and curcuminoids. IX: Investigation of the photobiological activity of curcumin using bacterial indicator systems. Journal of Pharmaceutical Sciences, 76: 371-373. Go to original source... Go to PubMed...
  177. Tourkina E., Gooz P., Oates J.C., Ludwicka-Bradley A., Silver R.M., Hoffman S. (2004): Curcumin-induced apoptosis in scleroderma lung fibroblasts: role of protein kinase cepsilon. American Journal of Respiratory Cell and Molecular Biology, 1: 28-35. Go to original source... Go to PubMed...
  178. Vajragupta O., Boonchoong P., Morris G.M., Olson A.J. (2005): Active site binding modes of curcumin in HIV-1 protease and integrase. Bioorganic and Medicinal Chemistry Letters, 15: 3364-3368. Go to original source... Go to PubMed...
  179. Vamvouris T., Hadi S. (2006): A review of the treatment of psoriasis with infliximab. Reviews on Recent Clinical Trials, 1: 201-205. Go to original source... Go to PubMed...
  180. Van Erk M.J., Teuling E., Staal Y.C., Huybers S., Van Bladeren P.J., Aarts J.M., Van Ommen B. (2004): Time- and dosedependent effects of curcumin on gene expression in human colon cancer cells. Journal of Carcinogenesis, 3: 8. doi: 10.1186/1477-3163-3-8 Go to original source... Go to PubMed...
  181. Vareed S.K., Kakarala M., Ruffin M.T., Crowell J.A., Normolle D.P., Djuric Z., Brenner D.E. (2008): Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects. Cancer Epidemiology, Biomarkers and Prevention, 17: 1411-1417. Go to original source... Go to PubMed...
  182. Veldman E.R., Jia Z., Halldin C., Svedberg M.M. (2016): Amyloid binding properties of curcumin analogues in Alzheimer's disease postmortem brain tissue. Neuroscience Letters, 630: 183-188. Go to original source... Go to PubMed...
  183. Wang Y.J., Pan M.H., Cheng A.L., Lin L.I., Ho Y.S., Hsieh C.Y., Lin J.K. (1997): Stability of curcumin in buffer solutions and characterization of its degradation products. Journal Pharmaceutical and Biomedical Analysis, 15: 1867-1876. Go to original source... Go to PubMed...
  184. Wang D., Veena M.S., Stevenson K., Tang C., Ho B., Suh J.D., Duarte V.M., Faull K.F., Mehta K., Srivatsan E.S., Wang M.B. (2008a): Liposome-encapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor κB by an AKT-independent pathway. Clinical Cancer Research, 14: 6228-6236. Go to original source... Go to PubMed...
  185. Wang R., Li Y.B., Li Y.H., Xu Y., Wu H.L., Li X.J. (2008b): Curcumin protects against glutamate excitotoxicity in rat cerebral cortical neurons by increasing brain-derived neurotrophic factor level and activating TrkB. Brain Research, 1210: 84-91. Go to original source... Go to PubMed...
  186. Wang R., Xu Y., Wu H.L., Li Y.B., Li Y.H., Guo J.B., Li X.J. (2008c): The antidepressant effects of curcumin in the forced swimming test involve 5-HT1 and 5-HT2 receptors. European Journal of Pharmacology, 578: 43-50. Go to original source... Go to PubMed...
  187. Wang N., Wang F., Gao Y., Yin P., Pan C., Liu W., Zhou Z., Wang J. (2016): Curcumin protects human adiposederived mesenchymal stem cells against oxidative stress-induced inhibition of osteogenesis. Journal of Pharmacological Sciences, 132: 192-200. Go to original source... Go to PubMed...
  188. Weber K.T. (2003): A neuroendocrine-immune interface. The immunostimulatory state of aldosteronism. Herz, 28: 692-701. Go to original source... Go to PubMed...
  189. Weber W.M., Hunsaker L.A., Gonzales A.M., Heynekamp J.J., Orlando R.A., Deck L.M., Vander Jagt D.L. (2006): TPA-induced up-regulation of activator protein-1 can be inhibited or enhanced by analogs of the natural product curcumin. Biochemical Pharmacology, 72: 928-940. Go to original source... Go to PubMed...
  190. Wongcharoen W., Phrommintikul A. (2009): The protective role of curcumin in cardiovascular diseases. International Journal of Cardiology, 133: 145-151. Go to original source... Go to PubMed...
  191. Wu L.X., Xu J.H., Wu G.H., Chen Y.Z. (2003a): Inhibitory effect of curcumin on proliferation of K562 cells involves downregulation of p210(bcr/abl) initiated Ras signal transduction pathway. Acta Pharmacologica Sinica, 24: 1155-1160.
  192. Xu J., Fu Y., Chen A. (2003b): Activation of peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth. American Journal of Physiology-Gastrointestinal and Liver Physiology, 285: 20-30. Go to original source... Go to PubMed...
  193. Xu M., Deng B., Chow Y.L., Zhao Z.Z., Hu B. (2007a): Effects of curcumin in treatment of experimental pulmonary fibrosis: a comparison with hydrocortisone. Journal of Ethnopharmacology, 112: 292-299. Go to original source... Go to PubMed...
  194. Xu W.S., Parmigiani R.B., Marks P.A. (2007b): Histone deacetylase inhibitors: molecular mechanisms of action. Oncogenesis, 26: 5541-5552. Go to original source... Go to PubMed...
  195. Xu Y., Ku B.S., Yao H.Y., Lin Y.H., Ma X., Zhang Y.H., Li X.J. (2005a): The effects of curcumin on depressive-like behaviors in mice. European Journal of Pharmacology, 518: 40-46. Go to original source... Go to PubMed...
  196. Xu Y., Ku B.S., Yao H.Y., Lin Y.H., Ma X., Zhang Y.H., Li X.J. (2005b): Antidepressant effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in rats. Pharmacology Biochemistry Behavior, 2: 200-206. Go to original source... Go to PubMed...
  197. Xu Y., Ku B., Tie L., Yao H., Jiang W., Ma X., Li X. (2006): Curcumin reverses the effects of chronic stress on behavior, the HPA axis, BDNF expression and phosphorylation of CREB. Brain Research, 112: 56-64. Go to original source... Go to PubMed...
  198. Xu Y., Ku B., Cui L., Li X., Barish P.A., Foster T.C., Ogle W.O. (2007): Curcumin reverses impaired hippocampal neurogenesis and increases serotonin receptor 1A mRNA and brain-derived neurotrophic factor expression in chronically stressed rats. Brain Research, 116: 9-18. Go to original source... Go to PubMed...
  199. Yang F., Lim G.P., Begum A.N., Ubeda O.J., Simmons M.R., Ambegaokar S.S., Chen P.P., Kayed R., Glabe C.G., Frautschy S.A., Cole G.M. (2005): Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. Journal of Biological Chemistry, 280: 5892-5901. Go to original source... Go to PubMed...
  200. Yang K.Y., Lin L.C., Tseng T.Y., Wang S.C., Tsai T.H. (2007): Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS. Journal of Chromatography, 853: 183-189. Go to original source... Go to PubMed...
  201. Yang M.W., Wang T.H., Yan P.P., Chu L.W., Yu J., Gao Z.D., Li Y.Z., Guo B.L. (2011): Curcumin improves bone microarchitecture and enhances mineral density in APP/PS1 transgenic mice. Phytomedicine, 18: 205-213. Go to original source... Go to PubMed...
  202. Yang J., Wang C., Zhang Z., Chen X., Jia Y., Wang B., Kong T. (2017): Curcumin inhibits the survival and metastasis of prostate cancer cells via the Notch-1 signaling pathway. APMIS, 125: 134-140. Go to original source... Go to PubMed...
  203. Yeon K.Y., Kim S.A., Kim Y.H., Lee M.K., Ahn D.K., Kim H.J., Kim J.S., Jung S.J., Oh S.B. (2010): Curcumin produces an antihyperalgesic effect via antagonism of TRPV1. Journal of Dental Research, 89: 170-174. Go to original source... Go to PubMed...
  204. Zeitlin P. (2004): Can curcumin cure cystic fibrosis? New England Journal Medicine, 351: 606-608. Go to original source... Go to PubMed...
  205. Zhang L., Diao R.Y., Duan Y.G., Yi T.H., Cai Z.M. (2017): In vitro antioxidant effect of curcumin on human sperm quality in leucocytospermia. Andrologia, e12760. doi: 10.1111/and.12760 Go to original source... Go to PubMed...
  206. Zhang Y., Xue Y.B., Li H., Qiu D., Wang Z.W., Tan S.S. (2017): Inhibition of cell survival by curcumin is associated with downregulation of cell division cycle 20 (Cdc20) in pancreatic cancer cells. Nutrients, 9: 109. doi: 10.3390/nu9020109 Go to original source... Go to PubMed...
  207. Zheng S., Yumei F., Chen A. (2007): De novo synthesis of glutathione is a prerequisite for curcumin to inhibit hepatic stellate cell (HSC) activation. Free Radical Biology and Medicine, 43: 444-453. Go to original source... Go to PubMed...
  208. Zheng R., Deng Q., Liu Y., Zhao P. (2017): Curcumin inhibits gastric carcinoma cell growth and induces apoptosis by suppressing the Wnt/β-catenin signaling pathway. Medical Science Monitor, 23: 163-171. Recived: 2015-12-29 Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.